BRINGING THE WORLD’S LEADING RESARCHERS TOGETHER TO FOCUS ON GLIOMATOSIS CEREBRI

In 2025, the international research community came together to advance our understanding of gliomatosis cerebri (GC) — a rare and devastating form of pediatric brain tumor that spreads diffusely through the brain and currently has no cure. At the 5th International Gliomatosis Cerebri Conference, scientists, clinicians, and family advocates from around the world convened to share breakthroughs, spark new collaborations, and accelerate progress toward better treatments and outcomes for affected children and families.

The meeting was co-chaired by Dr. Jeffrey P. Greenfield, Co-Director of the Children’s Brain Tumor Project at Weill Cornell Medicine and one of the leaders in gliomatosis cerebri research. Alongside global partners, Dr. Greenfield helped curate a scientific program that emphasized shared discovery and actionable next steps.

We were especially proud to see Michael Farid — Rudin Fellow at the Children’s Brain Tumor Project — present his research, showcasing the next generation of investigators making meaningful contributions to this field. Carolina Cocito, Instructor and member of the CBTP team, also participated as a featured attendee and leader, further representing our commitment to collaborative science and expertise in gliomatosis cerebri research.

These focused international meetings are crucial because no single institution sees enough cases of gliomatosis cerebri to solve its mysteries alone. By bringing together specialists who can share data, discuss early findings, and plan cooperative studies, the field gains not just knowledge — but a shared roadmap for progress.

Collaborations like this fuel the Children’s Brain Tumor Project’s mission to unlock the biology of rare pediatric brain tumors to gain better understanding of tumor behavior. As global leaders continue to work side-by-side, we remain hopeful that shared insight will one day translate into better options and better outcomes for the children we serve.